Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Hydroxychloroquine

EU orphan designation number: EU/3/16/1820   
Active ingredient: Hydroxychloroquine
Indication: Treatment of antiphospholipid syndrome
Sponsor: Centre Hospitalier Universitaire d'Angers
4 rue Larrey, 49933 Angers Cedex 9, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2017 Orphan designation EMA/OD/213/16 (2017)224 of 12/01/2017